Scientific Instrument & Hardware Makers

Health insurance plans routinely deny coverage for prosthetic limbs by claiming they are not medically necessary or are experimental devices, even for microprocessor-controlled knees that have been in use for decades. An estimated 2.3 million people in the United States live with limb loss, a number expected to double in coming years due to diabetes, trauma, and ageing. Fewer than half of people with limb loss have been prescribed a prosthesis. Between 2016 and 2019, Medicare beneficiaries paid an average of USD 3,580 out-of-pocket per new limb, while Medicare covered USD 13,546. Only about half of states have passed "insurance fairness" laws, and over half of people with private coverage are in plans not governed by state law. For custom prosthetic designers, these coverage gaps and caps directly constrain the market for advanced, individually fitted devices.

The average annual salary for a luthier in the United States is USD 47,358, or approximately USD 23 per hour -- well below the median U.S. household income. Very rarely will a luthier derive their entire income solely from building instruments; most shops supplement by offering repairs and trading instruments they did not build themselves. Productive bench time is limited to roughly four hours in an eight-hour day due to phone and email enquiries, vendor issues, convention attendance, and trips to source wood. Declining orchestral subscriptions, shrinking foundation grants, and reduced arts funding mean that purchasing a new handmade instrument is no longer a priority for many institutions. The profession is characterised by makers who accept below-market compensation because of passion for the craft, creating a systemic undervaluation of highly specialised manual labour that requires years of training.

The life science tools market is dominated by a handful of conglomerates that leverage scale, vertical integration, and aggressive M&A to crowd out independent instrument builders. Thermo Fisher Scientific disclosed a USD 40-50 billion M&A war-chest and completed a USD 4.1 billion acquisition of Solventum's purification and filtration business in February 2025, adding roughly USD 1 billion in bioprocess revenue. Danaher folded Genedata's bioinformatics stack into its portfolio in 2024 and completed its Abcam acquisition in December 2023. Flagship mass spectrometry platforms now surpass USD 1 million per unit, placing acquisition out of reach for smaller laboratories. These conglomerates leverage integrated portfolios to bundle design software, reagents, and analytics, putting price pressure on mid-tier and independent instrument makers who cannot match their cross-selling capabilities.

China holds approximately 38% of the global guitar export share, and in 2024 U.S. guitar imports increased by nearly 22% year-on-year to approximately USD 169 million. Factory-direct guitars from Chinese manufacturers cost 30-50% less than equivalent models made in the U.S., Europe, or Japan. Independent luthiers face a structural visibility problem: online marketplaces and retail channels are saturated with factory-produced instruments at price points that handmade builders cannot match. A custom handmade guitar requires 100-300 hours of skilled labour plus premium tonewoods and hardware, resulting in prices of USD 3,000-15,000, while factory guitars offering visually similar aesthetics retail for USD 200-800. Luthiers report that the volume of low-cost imports makes it increasingly difficult for buyers to discover or justify the investment in handcrafted instruments.

Open science hardware projects face a sustainability crisis mirroring the broader open-source funding gap: 60% of open-source maintainers remain unpaid for their work, according to the 2024 Tidelift State of the Open Source Maintainer Report. Many open science hardware projects emerge from academic labs or community initiatives but lack support to transition to self-sustaining operations. The Open Science Hardware Foundation was established to provide organisational support, fiscal sponsorship, and capacity building, but the fundamental tension persists: corporations and well-funded research institutions build on freely shared instrument designs while the original creators -- often early-career researchers or makers in the Global South -- capture no economic value. Open science hardware is generally perceived as lower quality than proprietary alternatives, creating a double bind where designers give away their work for free yet receive neither financial compensation nor professional recognition.

The 2025 tariff regime is reshaping the electronics supply chain in ways that disproportionately harm small and independent hardware makers. Russia, a key supplier of metals and minerals used in semiconductors, remains heavily sanctioned, and Ukraine's two largest semiconductor-grade neon producers -- responsible for 90% of U.S. neon supply -- shut down following the 2022 invasion, straining critical chip manufacturing inputs. Ongoing U.S.-China trade tensions have increased tariffs on semiconductor-related imports, reducing sourcing confidence and pipeline predictability. Small hardware engineers and scientific instrument builders lack the purchasing power to stockpile components or diversify suppliers across geographies. Unlike large manufacturers who can absorb tariff-driven cost increases, independent makers face existential risk: a single component becoming unavailable or doubling in price can render a custom instrument design financially unviable.